Skip to main content

Advertisement

Log in

Low yield of chemical shift MRI for characterization of adrenal lesions with high attenuation density on unenhanced CT

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Purpose

To investigate the threshold unenhanced CT density of adrenal nodules at which further evaluation with chemical shift MRI is unlikely to be definitive and therefore not helpful in further characterizing some indeterminate adrenal lesions.

Methods

Retrospective evaluation of 44 adrenal lesions imaged with unenhanced CT and chemical shift MRI and followed for at least 1 year. Qualitative and quantitative assessment of signal loss on chemical shift MRI was performed. Adenomas were diagnosed if the lesion measured equal or less than 10 HU on unenhanced CT; on MRI a SI index greater than 16.5% or adrenal:spleen chemical shift ratio less than 0.71 was considered diagnostic of adenoma.

Results

31.8% (14/44), 47.7% (21/44), and 20.5% (9/44) of the adrenal lesions had an unenhanced CT attenuation density ≤10, 10–30, and >30 HU. Adrenal lesions with an unenhanced CT density 10–30 and >30 HU had a 76.2% (16/21) and a 33.3% (3/9) chance of being categorized as an adenoma using MRI SI index, respectively.

Conclusions

Adrenal lesions with unenhanced attenuation CT density >30 HU had a 66.6% of remaining indeterminate even after evaluation with chemical shift MRI.

Advances in knowledge

Chemical shift MRI is reasonable for evaluating adrenal lesions with an unenhanced CT attenuation density less than 30 HU. The likelihood of chemical shift MRI detecting signal loss in lesions CT density greater than 30 HU, however, is low.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Korobkin M, Francis IR, Kloos RT, Dunnick NR (1996) The incidental adrenal mass. Radiol Clin North Am 34(5):1037–1054

    CAS  PubMed  Google Scholar 

  2. Song JH, Chaudhry FS, Mayo-Smith WW (2008) The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 190(5):1163–1168

    Article  PubMed  Google Scholar 

  3. Costa MAB, Carvalho TN, Araújo CR Jr, et al. (2005) Extrapulmonary manifestations of Manifestações extrapulmonares da paracoccidioidomycosis. Radiol Bras 38(1):45–52

    Article  Google Scholar 

  4. Sinelnikov AO, Abujudeh HH, Chan D, Novelline RA (2007) CT manifestations of adrenal trauma: experience with 73 cases. Emerg Radiol 13(6):313–318

    Article  PubMed  Google Scholar 

  5. Lam KY, Lo CY (2002) Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital. Clin Endocrinol 56(1):95–101

    Article  Google Scholar 

  6. Boland GW, Lee MJ, Gazelle GS, et al. (1998) Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171(1):201–204

    Article  CAS  PubMed  Google Scholar 

  7. Lee MJ, Hahn PF, Papanicolaou N, et al. (1991) Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 179(2):415–418

    Article  CAS  PubMed  Google Scholar 

  8. Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM (1992) Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 185(2):345–351

    Article  CAS  PubMed  Google Scholar 

  9. Korobkin M, Brodeur FJ, Yutzy GG, et al. (1996) Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol 166(3):531–536

    Article  CAS  PubMed  Google Scholar 

  10. Blake MA, Kalra MK, Sweeney AT, et al. (2006) Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 238(2):578–585

    Article  PubMed  Google Scholar 

  11. Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR (2000) Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 175(5):1411–1415

    Article  CAS  PubMed  Google Scholar 

  12. Zeiger MA, Thompson GB, Duh QY, et al. (2009) The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract 15(Suppl 1):1–20

    Article  PubMed  Google Scholar 

  13. Berland LL, Silverman SG, Gore RM, et al. (2010) Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol 7(10):754–773

    Article  PubMed  Google Scholar 

  14. Haider MA, Ghai S, Jhaveri K, Lockwood G (2004) Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? Radiology 231(3):711–716

    Article  PubMed  Google Scholar 

  15. Israel GM, Korobkin M, Wang C, Hecht EN, Krinsky GA (2004) Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR Am J Roentgenol 183(1):215–219

    Article  PubMed  Google Scholar 

  16. Outwater EK, Siegelman ES, Huang AB, Birnbaum BA (1996) Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 200(3):749–752

    Article  CAS  PubMed  Google Scholar 

  17. Fujiyoshi F, Nakajo M, Fukukura Y, Tsuchimochi S (2003) Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation. AJR Am J Roentgenol 180(6):1649–1657

    Article  PubMed  Google Scholar 

  18. Seo JM, Park BK, Park SY, Kim CK (2014) Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT. AJR Am J Roentgenol 202(5):1043–1050

    Article  PubMed  Google Scholar 

  19. Schindera ST, Soher BJ, Delong DM, Dale BM, Merkle EM (2008) Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience. Radiology 248(1):140–147

    Article  PubMed  Google Scholar 

  20. Remer EM, Motta-Ramirez GA, Shepardson LB, Hamrahian AH, Herts BR (2006) CT histogram analysis in pathologically proven adrenal masses. AJR Am J Roentgenol 187(1):191–196

    Article  PubMed  Google Scholar 

  21. Jacques AE, Sahdev A, Sandrasagara M, et al. (2008) Adrenal phaeochromocytoma: correlation of MRI appearances with histology and function. Eur Radiol 18(12):2885–2892

    Article  PubMed  Google Scholar 

  22. Caoili EM, Korobkin M, Francis IR, et al. (2002) Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 222(3):629–633

    Article  PubMed  Google Scholar 

  23. Choi YA, Kim CK, Park BK, Kim B (2013) Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT. Radiology 266(2):514–520

    Article  PubMed  Google Scholar 

  24. Gupta RT, Ho LM, Marin D, et al. (2010) Dual-energy CT for characterization of adrenal nodules: initial experience. AJR Am J Roentgenol 194(6):1479–1483

    Article  PubMed  Google Scholar 

  25. Boland GW (2011) Adrenal imaging. Abdom Imaging 36(4):472–482

    Article  PubMed  Google Scholar 

  26. Bagheri B, Maurer AH, Cone L, Doss M, Adler L (2004) Characterization of the normal adrenal gland with 18F-FDG PET/CT. J Nucl Med 45(8):1340–1343

    PubMed  Google Scholar 

  27. Metser U, Miller E, Lerman H, et al. (2006) 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med 47(1):32–37

    PubMed  Google Scholar 

  28. Sancho JJ, Triponez F, Montet X, Sitges-Serra A (2012) Surgical management of adrenal metastases. Langenbecks Arch Surg 397(2):179–194

    Article  PubMed  Google Scholar 

  29. Low G, Dhliwayo H, Lomas DJ (2012) Adrenal neoplasms. Clin Radiol 67(10):988–1000

    Article  CAS  PubMed  Google Scholar 

  30. Renard J, Clerici T, Licker M, Triponez F (2011) Pheochromocytoma and abdominal paraganglioma. J Visc Surg 148(6):e409–e416

    Article  CAS  PubMed  Google Scholar 

  31. Varghese JC, Hahn PF, Papanicolaou N, et al. (1997) MR differentiation of phaeochromocytoma from other adrenal lesions based on qualitative analysis of T2 relaxation times. Clin Radiol 52(8):603–606

    Article  CAS  PubMed  Google Scholar 

  32. Merkle EM, Schindera ST (2007) MR imaging of the adrenal glands: 1.5T versus 3T. Magn Reson Imaging Clin N Am 15(3):365–372, vii

  33. Savci G, Yazici Z, Sahin N, Akgoz S, Tuncel E (2006) Value of chemical shift subtraction MRI in characterization of adrenal masses. AJR Am J Roentgenol 186(1):130–135

    Article  PubMed  Google Scholar 

  34. Blake MA, Krishnamoorthy SK, Boland GW, et al. (2003) Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma. AJR Am J Roentgenol 181(6):1663–1668

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio Carlos Westphalen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sebro, R., Aslam, R., Muglia, V.F. et al. Low yield of chemical shift MRI for characterization of adrenal lesions with high attenuation density on unenhanced CT. Abdom Imaging 40, 318–326 (2015). https://doi.org/10.1007/s00261-014-0208-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-014-0208-8

Keywords

Navigation